Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  114 results for ""Antineoplastic Combined Chemotherapy Protocols""

Your Filters

Geographic : japan
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

PD-1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study.

  • Authors : Kuboki Y; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.; Koyama T

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Arginase*/Arginase*/Arginase*/antagonists & inhibitors; Humans

  • Source: Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (8), pp. e6980.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Cost drivers associated with diffuse large B-cell lymphoma (DLBCL) in Japan: A structural equation model (SEM) analysis.

  • Authors : Tsutsué S; Celgene K.K., a Bristol Myers Squibb Company, Tokyo, Japan.; Makita S

Subjects: Antineoplastic Combined Chemotherapy Protocols* ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy; Humans

  • Source: PloS one [PLoS One] 2022 May 27; Vol. 17 (5), pp. e0269169. Date of Electronic Publication: 2022 May 27 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Phase 1 trial of entinostat as monotherapy and combined with exemestane in Japanese patients with hormone receptor-positive advanced breast cancer.

  • Authors : Masuda N; Department of Surgery, Breast Oncology, National Hospital Organization Osaka National Hospital, Osaka, Japan. .; Present address: Department of Breast and Endocrine Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. .

Subjects: Androstadienes/Androstadienes/Androstadienes/*therapeutic use ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use

  • Source: BMC cancer [BMC Cancer] 2021 Nov 24; Vol. 21 (1), pp. 1269. Date of Electronic Publication: 2021 Nov 24.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L).

  • Authors : Miyawaki T; Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology

  • Source: BMC cancer [BMC Cancer] 2021 Oct 18; Vol. 21 (1), pp. 1121. Date of Electronic Publication: 2021 Oct 18.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The prevalence of end-of-life chemotherapy and targeted therapy in Japan, assessed using a health claims database.

Subjects: *DATABASES; *ANTINEOPLASTIC combined chemotherapy protocols; *IMMUNE checkpoint inhibitorsJAPAN

  • Source: Cancer Chemotherapy & Pharmacology. Jun2023, Vol. 91 Issue 6, p501-506. 6p.

Record details

Read More Add to Saved list
×
Academic Journal

REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer.

  • Authors : Nakajima H; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.; Kotani D

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*blood ; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*drug therapy

  • Source: BMC cancer [BMC Cancer] 2021 Jun 07; Vol. 21 (1), pp. 674. Date of Electronic Publication: 2021 Jun 07.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

A randomized, double-blind, phase II study of oral histone deacetylase inhibitor resminostat plus S-1 versus placebo plus S-1 in biliary tract cancers previously treated with gemcitabine plus platinum-based chemotherapy.

  • Authors : Ueno M; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Kanagawa, Japan.; Morizane C

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Biliary Tract Neoplasms/Biliary Tract Neoplasms/Biliary Tract Neoplasms/*drug therapy ; Hydroxamic Acids/Hydroxamic Acids/Hydroxamic Acids/*therapeutic use

  • Source: Cancer medicine [Cancer Med] 2021 Mar; Vol. 10 (6), pp. 2088-2099. Date of Electronic Publication: 2021 Feb 26.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Palbociclib-letrozole as first-line treatment for advanced breast cancer: Updated results from a Japanese phase 2 study.

  • Authors : Takahashi M; National Hospital Organization Hokkaido Cancer Center, Hokkaido, Japan.; Masuda N

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy

  • Source: Cancer medicine [Cancer Med] 2020 Jul; Vol. 9 (14), pp. 4929-4940. Date of Electronic Publication: 2020 May 18.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.

  • Authors : Hirata K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. .; Hamamoto Y

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*administration & dosage ; Neoplasm Recurrence, Local/Neoplasm Recurrence, Local/Neoplasm Recurrence, Local/*drug therapy

  • Source: BMC cancer [BMC Cancer] 2020 Jun 12; Vol. 20 (1), pp. 548. Date of Electronic Publication: 2020 Jun 12.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan.

  • Authors : Ogata M; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe City, Hyogo, Japan.; Kotaka M

Subjects: Antineoplastic Combined Chemotherapy Protocols*; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*drug therapy ; Phenylurea Compounds/Phenylurea Compounds/Phenylurea Compounds/*therapeutic use

  • Source: PloS one [PLoS One] 2020 Jun 12; Vol. 15 (6), pp. e0234314. Date of Electronic Publication: 2020 Jun 12 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  114 results for ""Antineoplastic Combined Chemotherapy Protocols""